Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.
- DOI
- 10.1016/s1470-2045(25)00679-5
- Published
- 2026 Feb
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-25-00679-5,
title = {Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.},
author = {Wintner LM and Sztankay M and Abdel-Razeq H and Hamdan-Mansour R and Caocci G and Mouillet G and Kikawa Y and Shibata N and Krishnamurthy MN and Joshi A and Krishnatry R and Jain A and Pappot H and Petranović D and Trobentar A and Schmidt H and Schulze S and Tararykova A and Zabernigg A and Giesinger JM and Holzner B and EORTC Quality of Life Group},
year = {2026},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(25)00679-5},
url = {https://doi.org/10.1016/s1470-2045(25)00679-5}
}RIS
TY - JOUR TI - Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial. AU - Wintner LM AU - Sztankay M AU - Abdel-Razeq H AU - Hamdan-Mansour R AU - Caocci G AU - Mouillet G AU - Kikawa Y AU - Shibata N AU - Krishnamurthy MN AU - Joshi A AU - Krishnatry R AU - Jain A AU - Pappot H AU - Petranović D AU - Trobentar A AU - Schmidt H AU - Schulze S AU - Tararykova A AU - Zabernigg A AU - Giesinger JM AU - Holzner B AU - EORTC Quality of Life Group PY - 2026 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(25)00679-5 UR - https://doi.org/10.1016/s1470-2045(25)00679-5 ER -
APA
LM, W., M, S., H, A., R, H., G, C., G, M., Y, K., N, S., MN, K., A, J., R, K., A, J., H, P., D, P., A, T., H, S., S, S., A, T., A, Z., JM, G., B, H., & Group, E. Q. O. L. (2026). Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00679-5
Source records
- pubmed · retrieved 2026-09-27T08:14:26.905Z